News

Stay Updated! In The World Of Investments!
Sensex 48732.55 41.75 (0.09%)

Cipla Latest News

15

May, 2021

Cipla reports 68% rise in Q4 consolidated net profit

Cipla has reported results for fourth quarter and year ended March 31, 2021.

The company has reported a fall of 31.62% in its net profit at Rs 413.41 crore for the quarter under rev...

Read More

10

May, 2021

Cipla rises on signing licensing agreement with Eli Lilly

Cipla is currently trading at Rs. 894.85, up by 11.90 points or 1.35% from its previous closing of Rs. 882.95 on the BSE.

The scrip opened at Rs. 890.20 and has touched a high and l...

Read More

10

May, 2021

Cipla signs licensing agreement with Eli Lilly

Cipla has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company, USA for the manufacture and commercialization of the drug baricitinib for Covid-19 indication. Baricitinib was...

Read More

10

May, 2021

Cipla informs about press release

Cipla has informed that it has enclosed press release dated 10th May 2021 titled ‘Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India’.

Th...

Read More

05

May, 2021

Cipla jumps after its associate company incorporates wholly-owned subsidiary

Cipla is currently trading at Rs. 888.80, up by 10.25 points or 1.17% from its previous closing of Rs. 878.55 on the BSE.

The scrip opened at Rs. 885.00 and has touched a high and low of Rs. 899....

Read More

04

May, 2021

Cipla informs about updates

Cipla has informed that GoApptiv, an associate company of Cipla has incorporated a wholly-owned subsidiary company namely ‘Iconphygital Private Limited’ (with effective from 3rd May, 2021. ...

Read More

04

May, 2021

Cipla’s associate company incorporates wholly-owned subsidiary

Cipla’s associate company -- GoApptiv has incorporated a wholly-owned subsidiary company namely Iconphygital with effect from May 03, 2021. Iconphygital will be involved in the business of providing man-power ...

Read More

29

Apr, 2021

Cipla inches up on entering into licensing agreement with MSD

Cipla is currently trading at Rs. 910.90, up by 0.45 points or 0.05% from its previous closing of Rs. 910.45 on the BSE.

The scrip opened at Rs. 911.05 and has t...

Read More

28

Apr, 2021

Cipla enters into licensing agreement with MSD

Cipla has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral ...

Read More

24

Apr, 2021

Cipla informs about postal ballot notice

Cipla has informed that it has enclosed certified copy of the minutes of resolutions passed through postal ballot by way of remote evoting process on 25th March, 2021. The results of postal ballot were announced v...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback